Search
for
Sort by
Research 421–450 of 1000+
- Agent: Minoxidil
- Reporting on Adverse Clinical Events
- New Drugs: Dutasteride
- Pharmacology of anabolic steroids
- Treatment of invasive aspergillosis with itraconazole
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Nutritional factors and hair loss
- Female pattern hair loss
- Biomaterials Functionalized with MSC Secreted Extracellular Vesicles and Soluble Factors for Tissue Regeneration
- The diagnosis and treatment of iron deficiency and its potential relationship to hair loss
- Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products
- The PDGF/PDGFR pathway as a drug target
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- The Harmonies Played by TGF-β in Stem Cell Biology
- The pharmacology of methotrexate
- Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Exosomes for repair, regeneration and rejuvenation
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- Psoriasis of the Scalp
- Oxidative stress in ageing of hair
- Isotretinoin treatment of acne and related disorders: An update
- Extraskeletal actions of vitamin D
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Targeting the Wnt pathways for therapies